Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

How Much Chronic Depression With Medical Disorders Affect Work Performance?
A group of Australian researchers investigated in medical disorders the effects of comorbid dysthymic disorder as compared to major depressive disorder (MDD) on health-related quality of life (HR-QoL) and disability days in the general population. In a population-based study 4,181 individuals were assessed for the presence of dysthymic disorder and depression, utilizing the Composite International Diagnostic Interview. Each participant received a thorough medical examination to assess the presence of comorbid somatic conditions. HR-QoL was evaluated using the Medical Outcomes Survey Short-Form 36 (SF-36) and disability days were provided by self-report.

Joint Statement On Atypical Antipsychotic Use In Children
As advocates for people living with mental illnesses, we strongly urge the FDA to carefully consider the importance of viable treatment options for bipolar disorder and schizophrenia in pediatric and adolescent populations. Access to safe and effective treatments, including more information about all treatment options, is crucial to treating these serious and complex conditions in children and adolescents.
News of the day
Merck Partners With Non-Profit For Neglected Diseases Initiative
The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports. "The agreement covers drug candidates for illnesses like visceral leishmaniasis and Chagas disease, potentially lethal parasitic illnesses spread by insects. Current treatment for those illnesses may be toxic, or very expensive, or difficult to administer, Merck said," AP/CNBC writes (AP/CNBC, 6/22).
Health Insurance

Inovio Biomedical To Present At International DNA Vaccine Conference

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it will make multiple presentations at the Annual Conference of DNA Vaccines in Asia 2009 being hosted by the International Society of DNA Vaccines July 9 - 10 at the Beijing International Convention Center. The conference, with the theme, "Advancing DNA Vaccine Technology," is co-chaired by David B. Weiner, Ph.D., professor of pathology, University of Pennsylvania School of Medicine, and chairman of Inovio"s scientific advisory board. Inovio scientists and associates will be making the following presentations: Engineering Highly Immune Potent DNA Vaccines by Engineering Molecular Biology, Immunology and Physical Delivery In Vivo Presidential Address and Keynote Lecture David B. Weiner, Ph.D. Thursday July 9 08:30 - 09:05 Location: 305BC Immune Therapy by Electroporation Plenary Session 2 Iacob Mathiesen, Ph.D., Managing Director, Inovio AS Thursday July 9 11:00 - 12:10 Location: 305BC Pandemic and Seasonal Influenza DNA Vaccines Delivered via Electroporation Plenary Session 3 Niranjan Y. Sardesai, Ph.D., Sr. VP, Research & Development, Inovio Biomedical Thursday July 9 13:10 - 14:55 Location: 305BC Special Considerations for Multi-Component DNA Vaccine Production Plenary Session 7 Henry Hebel, Chief Operating Officer, VGXI Inc. Friday July 10 11:00 - 12:10 Location: 305BC Inovio Biomedical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009